secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2025-10-27T23:59:59+00:00
Accession:  0001823239-25-000113
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences reduces board from 11 to 8; three directors resign
-----------------------------------------------------------------------

- Benjamin Daverman, Jessica Hopfield, and Murali Prahalad resigned from the Board effective Oct 21, 2025.
- Board size reduced from 11 to 8 directors effective Oct 27, 2025; resignations were not due to any disagreement.
- R. Andrew Eckert named chair of Nominating, Governance and Risk Committee and member of Audit Committee.
- Gregory T. Lucier appointed to Nominating, Governance and Risk Committee; unvested RSUs for departing directors accelerated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323925000113/0001823239-25-000113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323925000113/mrvi-20251021.htm
  HTML page:      https://secwatch.observer/filing/0001823239-25-000113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer